CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	77.47	8.27	88.14	53.61
Short-Term Investments	489.04	179.41	55.34	0
Cash & Cash Equivalents	566.51	187.67	143.48	53.61
Cash Growth	294.83%	30.80%	167.65%	-
Receivables	0.15	0.09	0.3	0
Other Current Assets	11.95	6.36	3.42	4.8
Total Current Assets	578.61	194.12	147.21	58.41
Property, Plant & Equipment	0.45	0.49	0.51	0.2
Other Long-Term Assets	0.05	4.69	0.03	0.09
Total Long-Term Assets	0.5	5.18	0.54	0.29
Total Assets	579.11	199.3	147.75	58.69
Accounts Payable	4.66	3.24	0.99	1
Current Debt	0.22	0.22	9.16	3.02
Other Current Liabilities	5.11	10.8	5.29	1.96
Total Current Liabilities	9.98	14.25	15.43	5.98
Long-Term Debt	0.18	0.24	6.79	12.11
Other Long-Term Liabilities	0	0.01	0.35	0.35
Total Long-Term Liabilities	0.18	0.26	7.14	12.47
Total Liabilities	10.17	14.51	22.57	18.44
Total Debt	0.4	0.46	15.94	15.13
Debt Growth	-97.47%	-97.11%	5.39%	-
Retained Earnings	-146.87	-129.94	-81.34	-45.89
Shareholders' Equity	568.94	-123.1	-77.69	-42.62
Net Cash / Debt	566.1	187.21	127.54	38.48
Net Cash / Debt Growth	343.87%	46.79%	231.45%	-
Net Cash Per Share	-	43.23	34.09	10.54
Working Capital	568.63	179.87	131.78	52.43
Book Value Per Share	12.09	-28.42	-20.77	-11.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).